Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?

Identifieur interne : 002F44 ( Main/Corpus ); précédent : 002F43; suivant : 002F45

Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?

Auteurs : M. T. Herrero ; E. C. Hirsch ; A. Kastner ; M. Ruberg ; M. R. Luquin ; J. Laguna ; F. Javoy-Agid ; J. A. Obeso ; Y. Agid

Source :

RBID : ISTEX:A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7

English descriptors

Abstract

The question has been raised as to whether neuromelanin, a by-product of catecholamine metabolism which accumulates during aging in primate midbrain neurons, contributes to the selective vulnerability of subgroups of dopaminergic neurons in Parkinson's disease. 1-Methyl-4-phenylpyridinium (MPP+) a metabolite of 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) is toxic to dopaminergic neurons, particularly in primates, producing a motor syndrome similar to that observed in Parkinson's disease. To test whether this neurotoxin preferentially affects melanized neurons, the survival of melanized and non-melanized catecholaminergic neurons was analysed after MPTP intoxication in the midbrain of the cynomolgus monkey (Macaca fascicularis). Experiments were performed on six animals chronically treated with MPTP (two were severely disabled, four moderately affected) and two age-matched control monkeys.Two populations of neurons were examined on regularly spaced sections throughout the midbrain: catecholaminergic neurons, identified by tyrosine hydroxylase immunohistochemistry and neuromelanincontaining neurons, visualized by Masson's method. The total number of neurons of each type was estimated in the different midbrain catecholaminergic cell groups using computer assisted image analysis. In the midbrains of control animals not all catecholaminergic neurons contained neuromelanin. The percentage of melanized neurons compared to the total population of tyrosine hydroxylase-positive neurons was high in the substantia nigra pars compacta (81.5%) and in the locus coeruleus (98%), intermediate in the substantia nigra pars lateralis (70%), in the catecholaminergic cell group A8 (50%), and in the ventral tegmental area (41.5%) and almost nil in the central gray substance. In MPTP-treated monkeys, the severity of the loss of catecholaminergic neurons was variable within the different midbrain cell groups, though of similar intensity in severely and mildly disabled monkeys. A relationship was found between the loss of dopaminergic neurons in the different mesencephalic cell groups of MPTP-intoxicated animals and the percentage of melanized neurons they normally contain (r = 0.98; P = 0.04). The percentage loss of catecholaminergic neurons in the locus coeruleus, the only noradrenergic cell group studied, was lower than expected from the correlation curve obtained for dopaminergic cell groups.Altogether, these findings indicate:(i) that dopaminergic neurons are more vulnerable to MPTP-toxicity than noradrenergic neurons; and(ii) that among dopaminergic neurons, those containing neuromelanin are more susceptible, indicating a possible role of neuromelanin in MPTP-toxicity. Nevertheless, neuromelanin may only represent one of the factors involved in the neurotoxin-induced neuronal death, since some nigral melanized neurons also survive MPTP-intoxication.

Url:
DOI: 10.1016/0306-4522(93)90349-K

Links to Exploration step

ISTEX:A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?</title>
<author>
<name sortKey="Herrero, M T" sort="Herrero, M T" uniqKey="Herrero M" first="M. T." last="Herrero">M. T. Herrero</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kastner, A" sort="Kastner, A" uniqKey="Kastner A" first="A." last="Kastner">A. Kastner</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ruberg, M" sort="Ruberg, M" uniqKey="Ruberg M" first="M." last="Ruberg">M. Ruberg</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Luquin, M R" sort="Luquin, M R" uniqKey="Luquin M" first="M. R." last="Luquin">M. R. Luquin</name>
<affiliation>
<mods:affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Laguna, J" sort="Laguna, J" uniqKey="Laguna J" first="J." last="Laguna">J. Laguna</name>
<affiliation>
<mods:affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Javoy Agid, F" sort="Javoy Agid, F" uniqKey="Javoy Agid F" first="F." last="Javoy-Agid">F. Javoy-Agid</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Obeso, J A" sort="Obeso, J A" uniqKey="Obeso J" first="J. A." last="Obeso">J. A. Obeso</name>
<affiliation>
<mods:affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Y. Agid</name>
<affiliation>
<mods:affiliation>Departamento de Anatomía, Universidad de Navarra, 31080- Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7</idno>
<date when="1993" year="1993">1993</date>
<idno type="doi">10.1016/0306-4522(93)90349-K</idno>
<idno type="url">https://api.istex.fr/document/A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002F44</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?</title>
<author>
<name sortKey="Herrero, M T" sort="Herrero, M T" uniqKey="Herrero M" first="M. T." last="Herrero">M. T. Herrero</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kastner, A" sort="Kastner, A" uniqKey="Kastner A" first="A." last="Kastner">A. Kastner</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ruberg, M" sort="Ruberg, M" uniqKey="Ruberg M" first="M." last="Ruberg">M. Ruberg</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Luquin, M R" sort="Luquin, M R" uniqKey="Luquin M" first="M. R." last="Luquin">M. R. Luquin</name>
<affiliation>
<mods:affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Laguna, J" sort="Laguna, J" uniqKey="Laguna J" first="J." last="Laguna">J. Laguna</name>
<affiliation>
<mods:affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Javoy Agid, F" sort="Javoy Agid, F" uniqKey="Javoy Agid F" first="F." last="Javoy-Agid">F. Javoy-Agid</name>
<affiliation>
<mods:affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Obeso, J A" sort="Obeso, J A" uniqKey="Obeso J" first="J. A." last="Obeso">J. A. Obeso</name>
<affiliation>
<mods:affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Y. Agid</name>
<affiliation>
<mods:affiliation>Departamento de Anatomía, Universidad de Navarra, 31080- Pamplona, Spain</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Neuroscience</title>
<title level="j" type="abbrev">NSC</title>
<idno type="ISSN">0306-4522</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1993">1993</date>
<biblScope unit="volume">56</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="499">499</biblScope>
<biblScope unit="page" to="511">511</biblScope>
</imprint>
<idno type="ISSN">0306-4522</idno>
</series>
<idno type="istex">A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7</idno>
<idno type="DOI">10.1016/0306-4522(93)90349-K</idno>
<idno type="PII">0306-4522(93)90349-K</idno>
<idno type="ArticleID">9390349K</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0306-4522</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine</term>
<term>1-methyl-4-phenylpyridinium</term>
<term>LC</term>
<term>MPP+</term>
<term>MPTP</term>
<term>PAP</term>
<term>PB</term>
<term>TH</term>
<term>locus coeruleus</term>
<term>peroxidase-antiperoxidase</term>
<term>phosphate buffer</term>
<term>tyrosine hydroxylase</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The question has been raised as to whether neuromelanin, a by-product of catecholamine metabolism which accumulates during aging in primate midbrain neurons, contributes to the selective vulnerability of subgroups of dopaminergic neurons in Parkinson's disease. 1-Methyl-4-phenylpyridinium (MPP+) a metabolite of 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) is toxic to dopaminergic neurons, particularly in primates, producing a motor syndrome similar to that observed in Parkinson's disease. To test whether this neurotoxin preferentially affects melanized neurons, the survival of melanized and non-melanized catecholaminergic neurons was analysed after MPTP intoxication in the midbrain of the cynomolgus monkey (Macaca fascicularis). Experiments were performed on six animals chronically treated with MPTP (two were severely disabled, four moderately affected) and two age-matched control monkeys.Two populations of neurons were examined on regularly spaced sections throughout the midbrain: catecholaminergic neurons, identified by tyrosine hydroxylase immunohistochemistry and neuromelanincontaining neurons, visualized by Masson's method. The total number of neurons of each type was estimated in the different midbrain catecholaminergic cell groups using computer assisted image analysis. In the midbrains of control animals not all catecholaminergic neurons contained neuromelanin. The percentage of melanized neurons compared to the total population of tyrosine hydroxylase-positive neurons was high in the substantia nigra pars compacta (81.5%) and in the locus coeruleus (98%), intermediate in the substantia nigra pars lateralis (70%), in the catecholaminergic cell group A8 (50%), and in the ventral tegmental area (41.5%) and almost nil in the central gray substance. In MPTP-treated monkeys, the severity of the loss of catecholaminergic neurons was variable within the different midbrain cell groups, though of similar intensity in severely and mildly disabled monkeys. A relationship was found between the loss of dopaminergic neurons in the different mesencephalic cell groups of MPTP-intoxicated animals and the percentage of melanized neurons they normally contain (r = 0.98; P = 0.04). The percentage loss of catecholaminergic neurons in the locus coeruleus, the only noradrenergic cell group studied, was lower than expected from the correlation curve obtained for dopaminergic cell groups.Altogether, these findings indicate:(i) that dopaminergic neurons are more vulnerable to MPTP-toxicity than noradrenergic neurons; and(ii) that among dopaminergic neurons, those containing neuromelanin are more susceptible, indicating a possible role of neuromelanin in MPTP-toxicity. Nevertheless, neuromelanin may only represent one of the factors involved in the neurotoxin-induced neuronal death, since some nigral melanized neurons also survive MPTP-intoxication.</div>
</front>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<author>
<json:item>
<name>M.T. Herrero</name>
<affiliations>
<json:string>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>E.C. Hirsch</name>
<affiliations>
<json:string>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>A. Kastner</name>
<affiliations>
<json:string>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>M. Ruberg</name>
<affiliations>
<json:string>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>M.R. Luquin</name>
<affiliations>
<json:string>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</json:string>
</affiliations>
</json:item>
<json:item>
<name>J. Laguna</name>
<affiliations>
<json:string>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</json:string>
</affiliations>
</json:item>
<json:item>
<name>F. Javoy-Agid</name>
<affiliations>
<json:string>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>J.A. Obeso</name>
<affiliations>
<json:string>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</json:string>
</affiliations>
</json:item>
<json:item>
<name>Y. Agid</name>
<affiliations>
<json:string>Departamento de Anatomía, Universidad de Navarra, 31080- Pamplona, Spain</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>LC</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>locus coeruleus</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>MPP+</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>1-methyl-4-phenylpyridinium</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>MPTP</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PAP</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>peroxidase-antiperoxidase</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PB</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>phosphate buffer</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>TH</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tyrosine hydroxylase</value>
</json:item>
</subject>
<articleId>
<json:string>9390349K</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>The question has been raised as to whether neuromelanin, a by-product of catecholamine metabolism which accumulates during aging in primate midbrain neurons, contributes to the selective vulnerability of subgroups of dopaminergic neurons in Parkinson's disease. 1-Methyl-4-phenylpyridinium (MPP+) a metabolite of 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) is toxic to dopaminergic neurons, particularly in primates, producing a motor syndrome similar to that observed in Parkinson's disease. To test whether this neurotoxin preferentially affects melanized neurons, the survival of melanized and non-melanized catecholaminergic neurons was analysed after MPTP intoxication in the midbrain of the cynomolgus monkey (Macaca fascicularis). Experiments were performed on six animals chronically treated with MPTP (two were severely disabled, four moderately affected) and two age-matched control monkeys.Two populations of neurons were examined on regularly spaced sections throughout the midbrain: catecholaminergic neurons, identified by tyrosine hydroxylase immunohistochemistry and neuromelanincontaining neurons, visualized by Masson's method. The total number of neurons of each type was estimated in the different midbrain catecholaminergic cell groups using computer assisted image analysis. In the midbrains of control animals not all catecholaminergic neurons contained neuromelanin. The percentage of melanized neurons compared to the total population of tyrosine hydroxylase-positive neurons was high in the substantia nigra pars compacta (81.5%) and in the locus coeruleus (98%), intermediate in the substantia nigra pars lateralis (70%), in the catecholaminergic cell group A8 (50%), and in the ventral tegmental area (41.5%) and almost nil in the central gray substance. In MPTP-treated monkeys, the severity of the loss of catecholaminergic neurons was variable within the different midbrain cell groups, though of similar intensity in severely and mildly disabled monkeys. A relationship was found between the loss of dopaminergic neurons in the different mesencephalic cell groups of MPTP-intoxicated animals and the percentage of melanized neurons they normally contain (r = 0.98; P = 0.04). The percentage loss of catecholaminergic neurons in the locus coeruleus, the only noradrenergic cell group studied, was lower than expected from the correlation curve obtained for dopaminergic cell groups.Altogether, these findings indicate:(i) that dopaminergic neurons are more vulnerable to MPTP-toxicity than noradrenergic neurons; and(ii) that among dopaminergic neurons, those containing neuromelanin are more susceptible, indicating a possible role of neuromelanin in MPTP-toxicity. Nevertheless, neuromelanin may only represent one of the factors involved in the neurotoxin-induced neuronal death, since some nigral melanized neurons also survive MPTP-intoxication.</abstract>
<qualityIndicators>
<score>8</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>504 x 792 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>12</keywordCount>
<abstractCharCount>2891</abstractCharCount>
<pdfWordCount>5842</pdfWordCount>
<pdfCharCount>39658</pdfCharCount>
<pdfPageCount>13</pdfPageCount>
<abstractWordCount>383</abstractWordCount>
</qualityIndicators>
<title>Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?</title>
<pii>
<json:string>0306-4522(93)90349-K</json:string>
</pii>
<genre>
<json:string>research-article</json:string>
</genre>
<serie>
<volume>80</volume>
<pages>
<last>4550</last>
<first>4546</first>
</pages>
<genre></genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Proc. natn. Acad. Sci. U.S.A.</title>
</serie>
<host>
<volume>56</volume>
<pii>
<json:string>S0306-4522(00)X0428-9</json:string>
</pii>
<pages>
<last>511</last>
<first>499</first>
</pages>
<issn>
<json:string>0306-4522</json:string>
</issn>
<issue>2</issue>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Neuroscience</title>
<publicationDate>1993</publicationDate>
</host>
<categories>
<wos>
<json:string>NEUROSCIENCES</json:string>
</wos>
</categories>
<publicationDate>1993</publicationDate>
<copyrightDate>1993</copyrightDate>
<doi>
<json:string>10.1016/0306-4522(93)90349-K</json:string>
</doi>
<id>A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7/fulltext/pdf</uri>
</json:item>
<json:item>
<original>true</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7/fulltext/txt</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability>
<p>ELSEVIER</p>
</availability>
<date>1993</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?</title>
<author>
<persName>
<forename type="first">M.T.</forename>
<surname>Herrero</surname>
</persName>
<affiliation>To whom correspondence should be addressed at: INSERM U289.</affiliation>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">E.C.</forename>
<surname>Hirsch</surname>
</persName>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">A.</forename>
<surname>Kastner</surname>
</persName>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">M.</forename>
<surname>Ruberg</surname>
</persName>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">M.R.</forename>
<surname>Luquin</surname>
</persName>
<affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</affiliation>
</author>
<author>
<persName>
<forename type="first">J.</forename>
<surname>Laguna</surname>
</persName>
<affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</affiliation>
</author>
<author>
<persName>
<forename type="first">F.</forename>
<surname>Javoy-Agid</surname>
</persName>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
</author>
<author>
<persName>
<forename type="first">J.A.</forename>
<surname>Obeso</surname>
</persName>
<affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</affiliation>
</author>
<author>
<persName>
<forename type="first">Y.</forename>
<surname>Agid</surname>
</persName>
<affiliation>Departamento de Anatomía, Universidad de Navarra, 31080- Pamplona, Spain</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Neuroscience</title>
<title level="j" type="abbrev">NSC</title>
<idno type="pISSN">0306-4522</idno>
<idno type="PII">S0306-4522(00)X0428-9</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1993"></date>
<biblScope unit="volume">56</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="499">499</biblScope>
<biblScope unit="page" to="511">511</biblScope>
</imprint>
</monogr>
<idno type="istex">A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7</idno>
<idno type="DOI">10.1016/0306-4522(93)90349-K</idno>
<idno type="PII">0306-4522(93)90349-K</idno>
<idno type="ArticleID">9390349K</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1993</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>The question has been raised as to whether neuromelanin, a by-product of catecholamine metabolism which accumulates during aging in primate midbrain neurons, contributes to the selective vulnerability of subgroups of dopaminergic neurons in Parkinson's disease. 1-Methyl-4-phenylpyridinium (MPP+) a metabolite of 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) is toxic to dopaminergic neurons, particularly in primates, producing a motor syndrome similar to that observed in Parkinson's disease. To test whether this neurotoxin preferentially affects melanized neurons, the survival of melanized and non-melanized catecholaminergic neurons was analysed after MPTP intoxication in the midbrain of the cynomolgus monkey (Macaca fascicularis). Experiments were performed on six animals chronically treated with MPTP (two were severely disabled, four moderately affected) and two age-matched control monkeys.Two populations of neurons were examined on regularly spaced sections throughout the midbrain: catecholaminergic neurons, identified by tyrosine hydroxylase immunohistochemistry and neuromelanincontaining neurons, visualized by Masson's method. The total number of neurons of each type was estimated in the different midbrain catecholaminergic cell groups using computer assisted image analysis. In the midbrains of control animals not all catecholaminergic neurons contained neuromelanin. The percentage of melanized neurons compared to the total population of tyrosine hydroxylase-positive neurons was high in the substantia nigra pars compacta (81.5%) and in the locus coeruleus (98%), intermediate in the substantia nigra pars lateralis (70%), in the catecholaminergic cell group A8 (50%), and in the ventral tegmental area (41.5%) and almost nil in the central gray substance. In MPTP-treated monkeys, the severity of the loss of catecholaminergic neurons was variable within the different midbrain cell groups, though of similar intensity in severely and mildly disabled monkeys. A relationship was found between the loss of dopaminergic neurons in the different mesencephalic cell groups of MPTP-intoxicated animals and the percentage of melanized neurons they normally contain (r = 0.98; P = 0.04). The percentage loss of catecholaminergic neurons in the locus coeruleus, the only noradrenergic cell group studied, was lower than expected from the correlation curve obtained for dopaminergic cell groups.Altogether, these findings indicate:(i) that dopaminergic neurons are more vulnerable to MPTP-toxicity than noradrenergic neurons; and(ii) that among dopaminergic neurons, those containing neuromelanin are more susceptible, indicating a possible role of neuromelanin in MPTP-toxicity. Nevertheless, neuromelanin may only represent one of the factors involved in the neurotoxin-induced neuronal death, since some nigral melanized neurons also survive MPTP-intoxication.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Abbreviations</head>
<item>
<term>LC</term>
</item>
<item>
<term>locus coeruleus</term>
</item>
<item>
<term>MPP+</term>
</item>
<item>
<term>1-methyl-4-phenylpyridinium</term>
</item>
<item>
<term>MPTP</term>
</item>
<item>
<term>1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine</term>
</item>
<item>
<term>PAP</term>
</item>
<item>
<term>peroxidase-antiperoxidase</term>
</item>
<item>
<term>PB</term>
</item>
<item>
<term>phosphate buffer</term>
</item>
<item>
<term>TH</term>
</item>
<item>
<term>tyrosine hydroxylase</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="1993-04-06">Registration</change>
<change when="1993">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier doc found" wicri:toSee="Elsevier, no converted or simple article">
<istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 5.0.1//EN//XML" URI="art501.dtd" name="istex:docType"></istex:docType>
<istex:document>
<article version="5.0" xml:lang="en" docsubtype="fla">
<item-info>
<jid>NSC</jid>
<aid>9390349K</aid>
<ce:pii>0306-4522(93)90349-K</ce:pii>
<ce:doi>10.1016/0306-4522(93)90349-K</ce:doi>
<ce:copyright type="unknown" year="1993">IBRO</ce:copyright>
</item-info>
<head>
<ce:title>Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?</ce:title>
<ce:author-group>
<ce:author>
<ce:given-name>M.T.</ce:given-name>
<ce:surname>Herrero</ce:surname>
<ce:cross-ref refid="cor1">
<ce:sup>§</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="aff1">
<ce:sup>*</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="aff2">
<ce:sup></ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="aff2">
<ce:sup></ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>E.C.</ce:given-name>
<ce:surname>Hirsch</ce:surname>
<ce:cross-ref refid="aff1">
<ce:sup>*</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>A.</ce:given-name>
<ce:surname>Kastner</ce:surname>
<ce:cross-ref refid="aff1">
<ce:sup>*</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>M.</ce:given-name>
<ce:surname>Ruberg</ce:surname>
<ce:cross-ref refid="aff1">
<ce:sup>*</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>M.R.</ce:given-name>
<ce:surname>Luquin</ce:surname>
<ce:cross-ref refid="aff2">
<ce:sup></ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>J.</ce:given-name>
<ce:surname>Laguna</ce:surname>
<ce:cross-ref refid="aff2">
<ce:sup></ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>F.</ce:given-name>
<ce:surname>Javoy-Agid</ce:surname>
<ce:cross-ref refid="aff1">
<ce:sup>*</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>J.A.</ce:given-name>
<ce:surname>Obeso</ce:surname>
<ce:cross-ref refid="aff2">
<ce:sup></ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author>
<ce:given-name>Y.</ce:given-name>
<ce:surname>Agid</ce:surname>
<ce:cross-ref refid="aff3">
<ce:sup>*</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation id="aff1">
<ce:label>a</ce:label>
<ce:textfn>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</ce:textfn>
</ce:affiliation>
<ce:affiliation id="aff2">
<ce:label>b</ce:label>
<ce:textfn>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</ce:textfn>
</ce:affiliation>
<ce:affiliation id="aff3">
<ce:label>c</ce:label>
<ce:textfn>Departamento de Anatomía, Universidad de Navarra, 31080- Pamplona, Spain</ce:textfn>
</ce:affiliation>
<ce:correspondence id="cor1">
<ce:label>§</ce:label>
<ce:text>To whom correspondence should be addressed at: INSERM U289.</ce:text>
</ce:correspondence>
</ce:author-group>
<ce:date-accepted day="6" month="4" year="1993"></ce:date-accepted>
<ce:abstract id="ab1" class="author" xml:lang="en">
<ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec>
<ce:simple-para>The question has been raised as to whether neuromelanin, a by-product of catecholamine metabolism which accumulates during aging in primate midbrain neurons, contributes to the selective vulnerability of subgroups of dopaminergic neurons in Parkinson's disease. 1-Methyl-4-phenylpyridinium (MPP
<ce:sup>+</ce:sup>
) a metabolite of 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) is toxic to dopaminergic neurons, particularly in primates, producing a motor syndrome similar to that observed in Parkinson's disease. To test whether this neurotoxin preferentially affects melanized neurons, the survival of melanized and non-melanized catecholaminergic neurons was analysed after MPTP intoxication in the midbrain of the cynomolgus monkey (
<ce:italic>Macaca fascicularis</ce:italic>
). Experiments were performed on six animals chronically treated with MPTP (two were severely disabled, four moderately affected) and two age-matched control monkeys.</ce:simple-para>
<ce:simple-para>Two populations of neurons were examined on regularly spaced sections throughout the midbrain: catecholaminergic neurons, identified by tyrosine hydroxylase immunohistochemistry and neuromelanincontaining neurons, visualized by Masson's method. The total number of neurons of each type was estimated in the different midbrain catecholaminergic cell groups using computer assisted image analysis. In the midbrains of control animals not all catecholaminergic neurons contained neuromelanin. The percentage of melanized neurons compared to the total population of tyrosine hydroxylase-positive neurons was high in the substantia nigra pars compacta (81.5%) and in the locus coeruleus (98%), intermediate in the substantia nigra pars lateralis (70%), in the catecholaminergic cell group A8 (50%), and in the ventral tegmental area (41.5%) and almost nil in the central gray substance. In MPTP-treated monkeys, the severity of the loss of catecholaminergic neurons was variable within the different midbrain cell groups, though of similar intensity in severely and mildly disabled monkeys. A relationship was found between the loss of dopaminergic neurons in the different mesencephalic cell groups of MPTP-intoxicated animals and the percentage of melanized neurons they normally contain (
<ce:italic>r = 0.98; P = 0.04</ce:italic>
). The percentage loss of catecholaminergic neurons in the locus coeruleus, the only noradrenergic cell group studied, was lower than expected from the correlation curve obtained for dopaminergic cell groups.</ce:simple-para>
<ce:simple-para>Altogether, these findings indicate:
<ce:list>
<ce:list-item>
<ce:para>(i) that dopaminergic neurons are more vulnerable to MPTP-toxicity than noradrenergic neurons; and</ce:para>
</ce:list-item>
<ce:list-item>
<ce:para>(ii) that among dopaminergic neurons, those containing neuromelanin are more susceptible, indicating a possible role of neuromelanin in MPTP-toxicity. Nevertheless, neuromelanin may only represent one of the factors involved in the neurotoxin-induced neuronal death, since some nigral melanized neurons also survive MPTP-intoxication.</ce:para>
</ce:list-item>
</ce:list>
</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
<ce:keywords class="keyword" xml:lang="en">
<ce:section-title>Abbreviations</ce:section-title>
<ce:keyword>
<ce:text>LC</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>locus coeruleus</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>MPP
<ce:sup>+</ce:sup>
</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>1-methyl-4-phenylpyridinium</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>MPTP</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>PAP</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>peroxidase-antiperoxidase</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>PB</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>phosphate buffer</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>TH</ce:text>
</ce:keyword>
<ce:keyword>
<ce:text>tyrosine hydroxylase</ce:text>
</ce:keyword>
</ce:keywords>
</head>
<tail>
<ce:bibliography>
<ce:section-title>Reference</ce:section-title>
<ce:bibliography-sec>
<ce:bib-reference id="bib1">
<ce:label>1.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Bannon</ce:surname>
<ce:given-name>M.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Goedert</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Williams</ce:surname>
<ce:given-name>B.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>The possible relation of glutathione, melanin, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Biochem. Pharmac.</sb:maintitle>
</sb:title>
<sb:volume-nr>33</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>2697</sb:first-page>
<sb:last-page>2698</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib2">
<ce:label>2.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Bloem</ce:surname>
<ce:given-name>B.R.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Irwin</ce:surname>
<ce:given-name>I.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Buruma</ce:surname>
<ce:given-name>O.J.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Haan</ce:surname>
<ce:given-name>J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Roos</ce:surname>
<ce:given-name>R.A.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Tetrud</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Langston</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>J. neurol. Sci.</sb:maintitle>
</sb:title>
<sb:volume-nr>97</sb:volume-nr>
</sb:series>
<sb:date>1990</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>273</sb:first-page>
<sb:last-page>293</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib3">
<ce:label>3.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Burns</ce:surname>
<ce:given-name>R.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Chiueh</ce:surname>
<ce:given-name>C.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Markey</ce:surname>
<ce:given-name>S.P.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Ebert</ce:surname>
<ce:given-name>M.H.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Jacobowitz</ce:surname>
<ce:given-name>D.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Kopin</ce:surname>
<ce:given-name>I.J.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by
<ce:italic>N</ce:italic>
-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:book-series>
<sb:series>
<sb:title>
<sb:maintitle>Proc. natn. Acad. Sci. U.S.A.</sb:maintitle>
</sb:title>
<sb:volume-nr>80</sb:volume-nr>
</sb:series>
</sb:book-series>
<sb:date>1983</sb:date>
</sb:edited-book>
<sb:pages>
<sb:first-page>4546</sb:first-page>
<sb:last-page>4550</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib4">
<ce:label>4.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Campbell</ce:surname>
<ce:given-name>K.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Takada</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hattori</ce:surname>
<ce:given-name>T.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Evidence for retrograde axonal transport of MPP
<ce:sup>+</ce:sup>
in the rat</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neurosci. Lett.</sb:maintitle>
</sb:title>
<sb:volume-nr>118</sb:volume-nr>
</sb:series>
<sb:date>1990</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>151</sb:first-page>
<sb:last-page>154</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib5">
<ce:label>5.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Chiba</ce:surname>
<ce:given-name>K.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Trevor</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Castagnoli</ce:surname>
<ce:given-name>N.</ce:given-name>
<ce:suffix>Jr</ce:suffix>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamino oxidase</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Biochem. biophys. Res. Commun.</sb:maintitle>
</sb:title>
<sb:volume-nr>120</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>574</sb:first-page>
<sb:last-page>578</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib6">
<ce:label>6.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Cohen</ce:surname>
<ce:given-name>G.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>The pathophysiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>J. neural Transm., Suppl.</sb:maintitle>
</sb:title>
<sb:volume-nr>19</sb:volume-nr>
</sb:series>
<sb:date>1983</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>89</sb:first-page>
<sb:last-page>103</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib7">
<ce:label>7.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Dahlström</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Fuxe</ce:surname>
<ce:given-name>K.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurones</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Acta physiol. scand.</sb:maintitle>
</sb:title>
<sb:volume-nr>62</sb:volume-nr>
</sb:series>
<sb:issue-nr>suppl. 232</sb:issue-nr>
<sb:date>1964</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>17</sb:first-page>
<sb:last-page>25</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib8">
<ce:label>8.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>D'Amato</ce:surname>
<ce:given-name>R.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Benham</ce:surname>
<ce:given-name>D.F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Snyder</ce:surname>
<ce:given-name>S.H.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Characterization of the binding of
<ce:italic>N</ce:italic>
-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin
<ce:italic>N</ce:italic>
-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>J. Neurochem.</sb:maintitle>
</sb:title>
<sb:volume-nr>48</sb:volume-nr>
</sb:series>
<sb:date>1987</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>653</sb:first-page>
<sb:last-page>658</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib9">
<ce:label>9.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>D'Amato</ce:surname>
<ce:given-name>R.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Alexander</ce:surname>
<ce:given-name>G.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Schwartzman</ce:surname>
<ce:given-name>R.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Kitt</ce:surname>
<ce:given-name>C.A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Price</ce:surname>
<ce:given-name>D.L.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Snyder</ce:surname>
<ce:given-name>S.H.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Evidence for neuromelanin involvement in MPTP-neurotoxicity</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Nature</sb:maintitle>
</sb:title>
<sb:volume-nr>327</sb:volume-nr>
</sb:series>
<sb:date>1987</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>324</sb:first-page>
<sb:last-page>326</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib10">
<ce:label>10.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Daniels</ce:surname>
<ce:given-name>A.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Reinhard</ce:surname>
<ce:given-name>J.F.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>J. biol. Chem.</sb:maintitle>
</sb:title>
<sb:volume-nr>263</sb:volume-nr>
</sb:series>
<sb:date>1988</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>5034</sb:first-page>
<sb:last-page>5036</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib11">
<ce:label>11.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Deustch</ce:surname>
<ce:given-name>A.Y.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Elsworth</ce:surname>
<ce:given-name>J.D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Goldstein</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Fuxe</ce:surname>
<ce:given-name>K.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Redmond</ce:surname>
<ce:given-name>D.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Sladek</ce:surname>
<ce:given-name>J.R.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Roth</ce:surname>
<ce:given-name>R.H.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Preferential vulnerability of the A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neurosci. Lett.</sb:maintitle>
</sb:title>
<sb:volume-nr>68</sb:volume-nr>
</sb:series>
<sb:date>1986</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>51</sb:first-page>
<sb:last-page>56</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib12">
<ce:label>12.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Elsworth</ce:surname>
<ce:given-name>J.D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Deutch</ce:surname>
<ce:given-name>A.Y.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Redmond</ce:surname>
<ce:given-name>D.E.</ce:given-name>
<ce:suffix>Jr</ce:suffix>
</sb:author>
<sb:author>
<ce:surname>Sladek</ce:surname>
<ce:given-name>J.R.</ce:given-name>
<ce:suffix>Jr</ce:suffix>
</sb:author>
<sb:author>
<ce:surname>Roth</ce:surname>
<ce:given-name>R.H.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of primate substantia nigra and striatum</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Life Sci.</sb:maintitle>
</sb:title>
<sb:volume-nr>40</sb:volume-nr>
</sb:series>
<sb:date>1987</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>193</sb:first-page>
<sb:last-page>202</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib13">
<ce:label>13.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Fearnley</ce:surname>
<ce:given-name>J.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Lees</ce:surname>
<ce:given-name>A.J.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Ageing and Parkinson's disease: substantia nigra regional selectivity</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain</sb:maintitle>
</sb:title>
<sb:volume-nr>114</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>2283</sb:first-page>
<sb:last-page>2301</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib14">
<ce:label>14.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Forno</ce:surname>
<ce:given-name>L.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DeLanney</ce:surname>
<ce:given-name>L.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Langston</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Evolution of nerve cell degeneration in the MPTP-treated squirrel monkey</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:title>
<sb:maintitle>Abstracts from the first symposium on: Transmissible and non-transmissible neurodegenerative disorders</sb:maintitle>
</sb:title>
<sb:date>1993</sb:date>
<sb:publisher>
<sb:name>University of Göteborg</sb:name>
</sb:publisher>
</sb:edited-book>
<sb:pages>
<sb:first-page>4</sb:first-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib15">
<ce:label>15.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Forno</ce:surname>
<ce:given-name>L.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Langston</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DeLanney</ce:surname>
<ce:given-name>L.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Irwin</ce:surname>
<ce:given-name>I.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Ricaurte</ce:surname>
<ce:given-name>G.A.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Locus coeruleus lesions und eosinophilic inclusions in MPTP-treated monkeys</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Ann. Neurol.</sb:maintitle>
</sb:title>
<sb:volume-nr>20</sb:volume-nr>
</sb:series>
<sb:date>1986</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>449</sb:first-page>
<sb:last-page>455</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib16">
<ce:label>16.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Forno</ce:surname>
<ce:given-name>L.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Langston</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DeLanney</ce:surname>
<ce:given-name>L.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Irwin</ce:surname>
<ce:given-name>I.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>An electron microscopic study of MPTP-induced inclusion bodies in an old monkey</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>448</sb:volume-nr>
</sb:series>
<sb:date>1988</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>150</sb:first-page>
<sb:last-page>157</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib17">
<ce:label>17.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Gabe</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Techniques Histologiques</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:date>1968</sb:date>
<sb:publisher>
<sb:name>Masson et Cie</sb:name>
<sb:location>Paris</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages>
<sb:first-page>903</sb:first-page>
<sb:last-page>904</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib18">
<ce:label>18.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>German</ce:surname>
<ce:given-name>D.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Dubach</ce:surname>
<ce:given-name>M</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Askari</ce:surname>
<ce:given-name>S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Speciale</ce:surname>
<ce:given-name>S.G.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Bowden</ce:surname>
<ce:given-name>D.M.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neuroscience</sb:maintitle>
</sb:title>
<sb:volume-nr>24</sb:volume-nr>
</sb:series>
<sb:date>1988</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>161</sb:first-page>
<sb:last-page>174</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib19">
<ce:label>19.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>German</ce:surname>
<ce:given-name>D.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Manaye</ce:surname>
<ce:given-name>K.F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Brown</ce:surname>
<ce:given-name>J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Gerfen</ce:surname>
<ce:given-name>C.R.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Calcium-binding protein immunoreactivity in the human midbrain: relationship to dopaminergic neurons</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Soc. Neurosci. Abstr.</sb:maintitle>
</sb:title>
<sb:volume-nr>16</sb:volume-nr>
</sb:series>
<sb:date>1990</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>696</sb:first-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib20">
<ce:label>20.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Gibb</ce:surname>
<ce:given-name>W.R.G.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>581</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>283</sb:first-page>
<sb:last-page>291</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib21">
<ce:label>21.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Graham</ce:surname>
<ce:given-name>D.G.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>On the origin and significance of neuromelanin</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Arch. Path. Lab. Med.</sb:maintitle>
</sb:title>
<sb:volume-nr>103</sb:volume-nr>
</sb:series>
<sb:date>1979</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>359</sb:first-page>
<sb:last-page>362</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib22">
<ce:label>22.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Graybiel</ce:surname>
<ce:given-name>A.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Agid</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Differences in tyrosine hydroxylase-immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:book-series>
<sb:series>
<sb:title>
<sb:maintitle>Proc. natn. Acad. Sci. U.S.A.</sb:maintitle>
</sb:title>
<sb:volume-nr>84</sb:volume-nr>
</sb:series>
</sb:book-series>
<sb:date>1987</sb:date>
</sb:edited-book>
<sb:pages>
<sb:first-page>303</sb:first-page>
<sb:last-page>307</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib23">
<ce:label>23.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Graybiel</ce:surname>
<ce:given-name>A.M.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Dopaminergic and cholinergic systems in the striatum</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:editors>
<sb:editor>
<ce:surname>Crossman</ce:surname>
<ce:given-name>A.R.</ce:given-name>
</sb:editor>
<sb:editor>
<ce:surname>Sambrook</ce:surname>
<ce:given-name>M.A.</ce:given-name>
</sb:editor>
</sb:editors>
<sb:title>
<sb:maintitle>Neural Mechanisms in Disorders of Movement</sb:maintitle>
</sb:title>
<sb:date>1989</sb:date>
<sb:publisher>
<sb:name>John Libbey</sb:name>
<sb:location>London</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages>
<sb:first-page>3</sb:first-page>
<sb:last-page>15</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib24">
<ce:label>24.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Heikkila</ce:surname>
<ce:given-name>R.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Manzino</ce:surname>
<ce:given-name>L.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Cabbat</ce:surname>
<ce:given-name>F.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Duvoisin</ce:surname>
<ce:given-name>R.C.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Protection against dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamino oxidase inhibitors</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Nature</sb:maintitle>
</sb:title>
<sb:volume-nr>311</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>467</sb:first-page>
<sb:last-page>469</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib25">
<ce:label>25.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Herkenham</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Little</ce:surname>
<ce:given-name>M.D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Bankiewicz</ce:surname>
<ce:given-name>K.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Yang</ce:surname>
<ce:given-name>S.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Markey</ce:surname>
<ce:given-name>S.P.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Johannessen</ce:surname>
<ce:given-name>J.N.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Selective retention of MPP + within the monoaminergic systems of the primate brain following MPTP administration: an
<ce:italic>in vivo</ce:italic>
autoradiographic study</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neuroscience</sb:maintitle>
</sb:title>
<sb:volume-nr>40</sb:volume-nr>
</sb:series>
<sb:date>1991</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>133</sb:first-page>
<sb:last-page>158</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib26">
<ce:label>26.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Herrero</ce:surname>
<ce:given-name>M.T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Kastner</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Luquin</ce:surname>
<ce:given-name>M.R.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Javoy-Agid</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Gonzalo</ce:surname>
<ce:given-name>L.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Obeso</ce:surname>
<ce:given-name>J.A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Agid</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Neuromelanin accumulation with age in catecholaminergic neurons from
<ce:italic>Macaca fascicularis</ce:italic>
brainstem</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Devl. Neurosci</sb:maintitle>
</sb:title>
</sb:series>
<sb:date>1993</sb:date>
</sb:issue>
</sb:host>
<sb:comment>(in press).</sb:comment>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib27">
<ce:label>27.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Graybiel</ce:surname>
<ce:given-name>A.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Agid</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Nature</sb:maintitle>
</sb:title>
<sb:volume-nr>334</sb:volume-nr>
</sb:series>
<sb:date>1988</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>345</sb:first-page>
<sb:last-page>348</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib28">
<ce:label>28.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Brandel</ce:surname>
<ce:given-name>J.P.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Galle</ce:surname>
<ce:given-name>P.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Javoy-Agid</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Agid</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>J. Neurochem.</sb:maintitle>
</sb:title>
<sb:volume-nr>56</sb:volume-nr>
</sb:series>
<sb:date>1991</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>446</sb:first-page>
<sb:last-page>451</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib29">
<ce:label>29.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Ann. Neurol.</sb:maintitle>
</sb:title>
<sb:volume-nr>32</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>S88</sb:first-page>
<sb:last-page>S93</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib30">
<ce:label>30.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Mouatt</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Thomasset</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Javoy-Agid</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Agid</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Graybiel</ce:surname>
<ce:given-name>A.M.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Expression of calbindin D
<ce:inf>28K</ce:inf>
-like immunoreactivity in catecholaminergic cell groups of the human midbrain: normal distribution and distribution in Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neurodegeneration</sb:maintitle>
</sb:title>
<sb:volume-nr>1</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>83</sb:first-page>
<sb:last-page>93</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib31">
<ce:label>31.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Hoehn</ce:surname>
<ce:given-name>M.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Yahr</ce:surname>
<ce:given-name>M.D.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Parkinsonism: onset, progression and mortality</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neurology</sb:maintitle>
</sb:title>
<sb:volume-nr>17</sb:volume-nr>
</sb:series>
<sb:date>1967</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>427</sb:first-page>
<sb:last-page>442</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib32">
<ce:label>32.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Imai</ce:surname>
<ce:given-name>H.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Nakamura</ce:surname>
<ce:given-name>T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Endo</ce:surname>
<ce:given-name>K.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Narabayashi</ce:surname>
<ce:given-name>H.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>474</sb:volume-nr>
</sb:series>
<sb:date>1988</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>327</sb:first-page>
<sb:last-page>332</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib33">
<ce:label>33.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Irwin</ce:surname>
<ce:given-name>L.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DeLanney</ce:surname>
<ce:given-name>L.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Forno</ce:surname>
<ce:given-name>L.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Finnegan</ce:surname>
<ce:given-name>K.T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DiMonte</ce:surname>
<ce:given-name>D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Langston</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>531</sb:volume-nr>
</sb:series>
<sb:date>1990</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>242</sb:first-page>
<sb:last-page>252</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib34">
<ce:label>34.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Irwin</ce:surname>
<ce:given-name>L.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Finnegan</ce:surname>
<ce:given-name>K.T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DeLanney</ce:surname>
<ce:given-name>L.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DiMonte</ce:surname>
<ce:given-name>D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Langston</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>The relationships between aging, monoaminooxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>572</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>224</sb:first-page>
<sb:last-page>231</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib35">
<ce:label>35.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Jacobowitz</ce:surname>
<ce:given-name>D.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Burns</ce:surname>
<ce:given-name>R.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Chiueh</ce:surname>
<ce:given-name>C.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Kopin</ce:surname>
<ce:given-name>I.J.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>
<ce:italic>N</ce:italic>
-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Psychopharmac. Bull.</sb:maintitle>
</sb:title>
<sb:volume-nr>20</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>416</sb:first-page>
<sb:last-page>422</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib36">
<ce:label>36.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Javoy-Agid</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Dumas</ce:surname>
<ce:given-name>S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Duyckaerts</ce:surname>
<ce:given-name>C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Mallet</ce:surname>
<ce:given-name>J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Agid</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neuroscience</sb:maintitle>
</sb:title>
<sb:volume-nr>38</sb:volume-nr>
</sb:series>
<sb:date>1990</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>245</sb:first-page>
<sb:last-page>253</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib37">
<ce:label>37.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Kastner</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Lejeune</ce:surname>
<ce:given-name>O.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Javoy-Agid</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Rascol</ce:surname>
<ce:given-name>O.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Agid</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>J. Neurochem.</sb:maintitle>
</sb:title>
<sb:volume-nr>59</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>1080</sb:first-page>
<sb:last-page>1089</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib38">
<ce:label>38.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Kastner</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hirsch</ce:surname>
<ce:given-name>E.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Herrero</ce:surname>
<ce:given-name>M.T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Javoy-Agid</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Agid</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>J. Neurochem.</sb:maintitle>
</sb:title>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
</sb:host>
<sb:comment>(in press).</sb:comment>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib39">
<ce:label>39.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Kitt</ce:surname>
<ce:given-name>C.A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Cork</ce:surname>
<ce:given-name>L.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Eidelberg</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Joh</ce:surname>
<ce:given-name>T.H.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Price</ce:surname>
<ce:given-name>D.L.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neuroscience</sb:maintitle>
</sb:title>
<sb:volume-nr>17</sb:volume-nr>
</sb:series>
<sb:date>1986</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>1089</sb:first-page>
<sb:last-page>1103</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib40">
<ce:label>40.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Langston</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Forno</ce:surname>
<ce:given-name>L.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Rebert</ce:surname>
<ce:given-name>C.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Irwin</ce:surname>
<ce:given-name>I.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in squirrel monkey</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>292</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>390</sb:first-page>
<sb:last-page>394</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib41">
<ce:label>41.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Lavoie</ce:surname>
<ce:given-name>B.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Parent</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Relative sparing of dopaminergic neurons containing calbindin-28K in parkinsonian monkeys</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Soc. Neurosci. Abstr.</sb:maintitle>
</sb:title>
<sb:volume-nr>17</sb:volume-nr>
</sb:series>
<sb:date>1991</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>143</sb:first-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib42">
<ce:label>42.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Levi</ce:surname>
<ce:given-name>A.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DeMattei</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Ravazzani</ce:surname>
<ce:given-name>R.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Corvetti</ce:surname>
<ce:given-name>G.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Golden</ce:surname>
<ce:given-name>G.T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Fariello</ce:surname>
<ce:given-name>R.G.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in
<ce:italic>Macaca fascicularis</ce:italic>
</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neurosci. Lett.</sb:maintitle>
</sb:title>
<sb:volume-nr>96</sb:volume-nr>
</sb:series>
<sb:date>1989</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>271</sb:first-page>
<sb:last-page>276</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib43">
<ce:label>43.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Lindquist</ce:surname>
<ce:given-name>N.G.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Accumulation of drugs on melanin</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Acta radiol.</sb:maintitle>
</sb:title>
<sb:volume-nr>325</sb:volume-nr>
</sb:series>
<sb:date>1973</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>S1</sb:first-page>
<sb:last-page>S92</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib44">
<ce:label>44.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Lison</ce:surname>
<ce:given-name>L.</ce:given-name>
</sb:author>
</sb:authors>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:book-series>
<sb:series>
<sb:title>
<sb:maintitle>Histochemie et Cytochimie Animales. Principles et Méthodes</sb:maintitle>
</sb:title>
<sb:volume-nr>Vol. 2</sb:volume-nr>
</sb:series>
</sb:book-series>
<sb:date>1960</sb:date>
<sb:publisher>
<sb:name>Gauthier-Villars</sb:name>
<sb:location>Paris</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages>
<sb:first-page>725</sb:first-page>
<sb:last-page>726</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib45">
<ce:label>45.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Liu</ce:surname>
<ce:given-name>Y.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Peter</ce:surname>
<ce:given-name>D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Roghani</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Schuldiner</ce:surname>
<ce:given-name>S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Privé</ce:surname>
<ce:given-name>G.G.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Eisenberg</ce:surname>
<ce:given-name>D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Brecha</ce:surname>
<ce:given-name>N.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Edwards</ce:surname>
<ce:given-name>R.H.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>A cDNA that suppresses MPP
<ce:sup>+</ce:sup>
toxicity encodes a vesicular amine transporter</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Cell</sb:maintitle>
</sb:title>
<sb:volume-nr>70</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>539</sb:first-page>
<sb:last-page>551</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib46">
<ce:label>46.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Luquin</ce:surname>
<ce:given-name>M.R.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Herrero</ce:surname>
<ce:given-name>M.T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Obeso</ce:surname>
<ce:given-name>J.A.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Parkinsonismo inducido por MPTP como modelo experimental de Enfermedad de Parkinson: Similitudes y diferencias</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neurol.</sb:maintitle>
</sb:title>
<sb:volume-nr>31</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>551</sb:first-page>
<sb:last-page>554</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib47">
<ce:label>47.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Lyden</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Bondesson</ce:surname>
<ce:given-name>U.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Larsson</ce:surname>
<ce:given-name>B.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Lindquist</ce:surname>
<ce:given-name>N.G.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Melanin affinity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, an inducer of chronic parkinsonism in humans</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Acta pharmac. toxicol.</sb:maintitle>
</sb:title>
<sb:volume-nr>53</sb:volume-nr>
</sb:series>
<sb:date>1983</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>429</sb:first-page>
<sb:last-page>432</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib48">
<ce:label>48.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Manaye</ce:surname>
<ce:given-name>K.F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Sonsalla</ce:surname>
<ce:given-name>P.K.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Brooks</ce:surname>
<ce:given-name>B.A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>German</ce:surname>
<ce:given-name>D.C.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Calbindin
<ce:inf>28K</ce:inf>
is located in the midbrain dopaminergic neurons which are resistant to MPTP-induced degeneration</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Soc. Neurosci. Abstr.</sb:maintitle>
</sb:title>
<sb:volume-nr>17</sb:volume-nr>
</sb:series>
<sb:date>1991</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>1275</sb:first-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib49">
<ce:label>49.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Mann</ce:surname>
<ce:given-name>D.M.A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Yates</ce:surname>
<ce:given-name>P.O.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Possible role of neuromelanin in the pathogenesis of Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Mech. Aging Devl</sb:maintitle>
</sb:title>
<sb:volume-nr>21</sb:volume-nr>
</sb:series>
<sb:date>1983</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>193</sb:first-page>
<sb:last-page>203</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib50">
<ce:label>50.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Markey</ce:surname>
<ce:given-name>S.P.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Johannessen</ce:surname>
<ce:given-name>J.N.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Chiueh</ce:surname>
<ce:given-name>C.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Burns</ce:surname>
<ce:given-name>R.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Herkenham</ce:surname>
<ce:given-name>M.A.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Nature</sb:maintitle>
</sb:title>
<sb:volume-nr>311</sb:volume-nr>
</sb:series>
<sb:date>1984</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>464</sb:first-page>
<sb:last-page>467</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib51">
<ce:label>51.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Marsden</ce:surname>
<ce:given-name>C.D.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Neuromelanin and Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>J. neural Transm., Suppl.</sb:maintitle>
</sb:title>
<sb:volume-nr>19</sb:volume-nr>
</sb:series>
<sb:date>1983</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>121</sb:first-page>
<sb:last-page>124</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib52">
<ce:label>52.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Mavridis</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Degryse</ce:surname>
<ce:given-name>A.-D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Lategan</ce:surname>
<ce:given-name>A.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Marien</ce:surname>
<ce:given-name>M.R.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Colpaert</ce:surname>
<ce:given-name>F.C.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neuroscience</sb:maintitle>
</sb:title>
<sb:volume-nr>41</sb:volume-nr>
</sb:series>
<sb:date>1991</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>507</sb:first-page>
<sb:last-page>523</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib53">
<ce:label>53.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Mitchell</ce:surname>
<ce:given-name>I.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Cross</ce:surname>
<ce:given-name>A.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Sambrook</ce:surname>
<ce:given-name>M.A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Crossman</ce:surname>
<ce:given-name>A.R.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neurosci. Lett.</sb:maintitle>
</sb:title>
<sb:volume-nr>61</sb:volume-nr>
</sb:series>
<sb:date>1985</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>195</sb:first-page>
<sb:last-page>200</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib54">
<ce:label>54.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Moratalla</ce:surname>
<ce:given-name>R.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Quinn</ce:surname>
<ce:given-name>B.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>DeLanney</ce:surname>
<ce:given-name>L.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Irwin</ce:surname>
<ce:given-name>I.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Langston</ce:surname>
<ce:given-name>J.W.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Graybiel</ce:surname>
<ce:given-name>A.M.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:book-series>
<sb:series>
<sb:title>
<sb:maintitle>Proc. natn. Acad. Sci. U.S.A.</sb:maintitle>
</sb:title>
<sb:volume-nr>89</sb:volume-nr>
</sb:series>
</sb:book-series>
<sb:date>1992</sb:date>
</sb:edited-book>
<sb:pages>
<sb:first-page>3859</sb:first-page>
<sb:last-page>3863</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib55">
<ce:label>55.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Olszewski</ce:surname>
<ce:given-name>J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Baxter</ce:surname>
<ce:given-name>D.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Cytoarchitecture of the Human Brainstem</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:book>
<sb:date>1954</sb:date>
<sb:publisher>
<sb:name>S. Karger</sb:name>
<sb:location>Basel</sb:location>
</sb:publisher>
</sb:book>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib56">
<ce:label>56.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Orrenius</ce:surname>
<ce:given-name>S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Burkitt</ce:surname>
<ce:given-name>M.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Kass</ce:surname>
<ce:given-name>G.E.N.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Dypbukt</ce:surname>
<ce:given-name>J.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Nicotera</ce:surname>
<ce:given-name>P.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Calcium ions and oxidative cell injury</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Ann. Neurol.</sb:maintitle>
</sb:title>
<sb:volume-nr>32</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>S33</sb:first-page>
<sb:last-page>S42</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib57">
<ce:label>57.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Pifl</ce:surname>
<ce:given-name>C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Schingnitz</ce:surname>
<ce:given-name>G.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hornykiewicz</ce:surname>
<ce:given-name>O.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Neuroscience</sb:maintitle>
</sb:title>
<sb:volume-nr>44</sb:volume-nr>
</sb:series>
<sb:date>1991</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>591</sb:first-page>
<sb:last-page>605</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib58">
<ce:label>58.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Sanchez-Ramos</ce:surname>
<ce:given-name>J.R.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hefti</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hollinden</ce:surname>
<ce:given-name>G.E.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Sick</ce:surname>
<ce:given-name>T.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Rosenthal</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Mechanisms of MPP+ neurotoxicity: oxyradical and mitochondrial inhibition hypothesis</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:editors>
<sb:editor>
<ce:surname>Hefti</ce:surname>
<ce:given-name>F.</ce:given-name>
</sb:editor>
<sb:editor>
<ce:surname>Weiner</ce:surname>
<ce:given-name>W.J.</ce:given-name>
</sb:editor>
</sb:editors>
<sb:title>
<sb:maintitle>Progress in Parkinson's Disease</sb:maintitle>
</sb:title>
<sb:date>1988</sb:date>
<sb:publisher>
<sb:name>Plenum Press</sb:name>
<sb:location>New York</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages>
<sb:first-page>145</sb:first-page>
<sb:last-page>153</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib59">
<ce:label>59.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Schapira</ce:surname>
<ce:given-name>A.H.V.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Mann</ce:surname>
<ce:given-name>V.N.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Cooper</ce:surname>
<ce:given-name>J.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Krige</ce:surname>
<ce:given-name>D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Jenner</ce:surname>
<ce:given-name>P.J.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Marsden</ce:surname>
<ce:given-name>C.D.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Mitochondrial function in Parkinson's disease</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Ann. Neurol.</sb:maintitle>
</sb:title>
<sb:volume-nr>32</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>S116</sb:first-page>
<sb:last-page>S124</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib60">
<ce:label>60.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Schneider</ce:surname>
<ce:given-name>J.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Yuwiler</ce:surname>
<ce:given-name>A.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Markham</ce:surname>
<ce:given-name>C.H.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>411</sb:volume-nr>
</sb:series>
<sb:date>1987</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>144</sb:first-page>
<sb:last-page>150</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib61">
<ce:label>61.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Swartz</ce:surname>
<ce:given-name>H.M.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Sarna</ce:surname>
<ce:given-name>T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Zecca</ce:surname>
<ce:given-name>L.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Modulation by neuromelanin of the availability and reactivity of metal ions</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Ann. Neurol.</sb:maintitle>
</sb:title>
<sb:volume-nr>32</sb:volume-nr>
</sb:series>
<sb:date>1992</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>S69</sb:first-page>
<sb:last-page>S75</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib62">
<ce:label>62.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Turner</ce:surname>
<ce:given-name>B.H.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Wilson</ce:surname>
<ce:given-name>J.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>McKenzie</ce:surname>
<ce:given-name>J.C.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Richtand</ce:surname>
<ce:given-name>N.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>MPTP produces a pattern of nigrostriatal degeneration which coincides with the mosaic organization of the caudate nucleus</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>473</sb:volume-nr>
</sb:series>
<sb:date>1988</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>60</sb:first-page>
<sb:last-page>64</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib63">
<ce:label>63.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Vacca</ce:surname>
<ce:given-name>L.L.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>“Double bridge” techniques of immunocytochemistry</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:editors>
<sb:editor>
<ce:surname>Bullock</ce:surname>
<ce:given-name>G.</ce:given-name>
</sb:editor>
<sb:editor>
<ce:surname>Petrusz</ce:surname>
<ce:given-name>P.</ce:given-name>
</sb:editor>
</sb:editors>
<sb:title>
<sb:maintitle>Techniques in Immunocytochemistry</sb:maintitle>
</sb:title>
<sb:date>1982</sb:date>
<sb:publisher>
<sb:name>Academic Press</sb:name>
<sb:location>London</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages>
<sb:first-page>155</sb:first-page>
<sb:last-page>182</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib64">
<ce:label>64.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Wilson</ce:surname>
<ce:given-name>J.S.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Turner</ce:surname>
<ce:given-name>B.H.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Morrow</ce:surname>
<ce:given-name>G.D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Hartman</ce:surname>
<ce:given-name>P.J.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>MPTP produces a mosaic-like pattern of terminal degeneration in the caudate nucleus of the dog</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>423</sb:volume-nr>
</sb:series>
<sb:date>1987</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>329</sb:first-page>
<sb:last-page>332</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib65">
<ce:label>65.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Yamada</ce:surname>
<ce:given-name>T.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>McGeer</ce:surname>
<ce:given-name>P.L.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Baimbridge</ce:surname>
<ce:given-name>K.G.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>McGeer</ce:surname>
<ce:given-name>E.G.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin D
<ce:inf>28K</ce:inf>
</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Brain Res.</sb:maintitle>
</sb:title>
<sb:volume-nr>526</sb:volume-nr>
</sb:series>
<sb:date>1991</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>303</sb:first-page>
<sb:last-page>307</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib66">
<ce:label>66.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Youdim</ce:surname>
<ce:given-name>M.B.H.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Ben-Sachar</ce:surname>
<ce:given-name>D.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Riederer</ce:surname>
<ce:given-name>P.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:issue>
<sb:series>
<sb:title>
<sb:maintitle>Acta neurol. scand.</sb:maintitle>
</sb:title>
<sb:volume-nr>126</sb:volume-nr>
</sb:series>
<sb:date>1989</sb:date>
</sb:issue>
<sb:pages>
<sb:first-page>47</sb:first-page>
<sb:last-page>54</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
<ce:bib-reference id="bib67">
<ce:label>67.</ce:label>
<sb:reference>
<sb:contribution>
<sb:authors>
<sb:author>
<ce:surname>Youdim</ce:surname>
<ce:given-name>M.B.H.</ce:given-name>
</sb:author>
<sb:author>
<ce:surname>Ben-Sachar</ce:surname>
<ce:given-name>D.</ce:given-name>
</sb:author>
</sb:authors>
<sb:title>
<sb:maintitle>The neurotoxic component in Parkinson's disease may involve iron-melanin interaction and lipid peroxidation in the substantia nigra</sb:maintitle>
</sb:title>
</sb:contribution>
<sb:host>
<sb:edited-book>
<sb:editors>
<sb:editor>
<ce:surname>Dostert</ce:surname>
<ce:given-name>P.</ce:given-name>
</sb:editor>
<sb:editor>
<ce:surname>Riederer</ce:surname>
<ce:given-name>P.</ce:given-name>
</sb:editor>
<sb:editor>
<ce:surname>Strolin-Benedetti</ce:surname>
<ce:given-name>M.</ce:given-name>
</sb:editor>
<sb:editor>
<ce:surname>Roncucci</ce:surname>
<ce:given-name>R.</ce:given-name>
</sb:editor>
</sb:editors>
<sb:title>
<sb:maintitle>Early Markers in Parkinson's and Alzheimer's Diseases</sb:maintitle>
</sb:title>
<sb:date>1990</sb:date>
<sb:publisher>
<sb:name>Springer</sb:name>
<sb:location>Wien</sb:location>
</sb:publisher>
</sb:edited-book>
<sb:pages>
<sb:first-page>111</sb:first-page>
<sb:last-page>122</sb:last-page>
</sb:pages>
</sb:host>
</sb:reference>
</ce:bib-reference>
</ce:bibliography-sec>
</ce:bibliography>
</tail>
</article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA">
<title>Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?</title>
</titleInfo>
<name type="personal">
<namePart type="given">M.T.</namePart>
<namePart type="family">Herrero</namePart>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
<description>To whom correspondence should be addressed at: INSERM U289.</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E.C.</namePart>
<namePart type="family">Hirsch</namePart>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A.</namePart>
<namePart type="family">Kastner</namePart>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.</namePart>
<namePart type="family">Ruberg</namePart>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.R.</namePart>
<namePart type="family">Luquin</namePart>
<affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.</namePart>
<namePart type="family">Laguna</namePart>
<affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Javoy-Agid</namePart>
<affiliation>INSERM U289, Hoˆpital de la Salpêtrière, 47, Boulevard de l'Hoˆpital, 75013 Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">J.A.</namePart>
<namePart type="family">Obeso</namePart>
<affiliation>Neurología Experimental, Universidad de Navarra, 31080- Pamplona, Spain</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Y.</namePart>
<namePart type="family">Agid</namePart>
<affiliation>Departamento de Anatomía, Universidad de Navarra, 31080- Pamplona, Spain</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article"></genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1993</dateIssued>
<dateValid encoding="w3cdtf">1993-04-06</dateValid>
<copyrightDate encoding="w3cdtf">1993</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract lang="en">The question has been raised as to whether neuromelanin, a by-product of catecholamine metabolism which accumulates during aging in primate midbrain neurons, contributes to the selective vulnerability of subgroups of dopaminergic neurons in Parkinson's disease. 1-Methyl-4-phenylpyridinium (MPP+) a metabolite of 1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) is toxic to dopaminergic neurons, particularly in primates, producing a motor syndrome similar to that observed in Parkinson's disease. To test whether this neurotoxin preferentially affects melanized neurons, the survival of melanized and non-melanized catecholaminergic neurons was analysed after MPTP intoxication in the midbrain of the cynomolgus monkey (Macaca fascicularis). Experiments were performed on six animals chronically treated with MPTP (two were severely disabled, four moderately affected) and two age-matched control monkeys.Two populations of neurons were examined on regularly spaced sections throughout the midbrain: catecholaminergic neurons, identified by tyrosine hydroxylase immunohistochemistry and neuromelanincontaining neurons, visualized by Masson's method. The total number of neurons of each type was estimated in the different midbrain catecholaminergic cell groups using computer assisted image analysis. In the midbrains of control animals not all catecholaminergic neurons contained neuromelanin. The percentage of melanized neurons compared to the total population of tyrosine hydroxylase-positive neurons was high in the substantia nigra pars compacta (81.5%) and in the locus coeruleus (98%), intermediate in the substantia nigra pars lateralis (70%), in the catecholaminergic cell group A8 (50%), and in the ventral tegmental area (41.5%) and almost nil in the central gray substance. In MPTP-treated monkeys, the severity of the loss of catecholaminergic neurons was variable within the different midbrain cell groups, though of similar intensity in severely and mildly disabled monkeys. A relationship was found between the loss of dopaminergic neurons in the different mesencephalic cell groups of MPTP-intoxicated animals and the percentage of melanized neurons they normally contain (r = 0.98; P = 0.04). The percentage loss of catecholaminergic neurons in the locus coeruleus, the only noradrenergic cell group studied, was lower than expected from the correlation curve obtained for dopaminergic cell groups.Altogether, these findings indicate:(i) that dopaminergic neurons are more vulnerable to MPTP-toxicity than noradrenergic neurons; and(ii) that among dopaminergic neurons, those containing neuromelanin are more susceptible, indicating a possible role of neuromelanin in MPTP-toxicity. Nevertheless, neuromelanin may only represent one of the factors involved in the neurotoxin-induced neuronal death, since some nigral melanized neurons also survive MPTP-intoxication.</abstract>
<subject lang="en">
<genre>Abbreviations</genre>
<topic>LC</topic>
<topic>locus coeruleus</topic>
<topic>MPP+</topic>
<topic>1-methyl-4-phenylpyridinium</topic>
<topic>MPTP</topic>
<topic>1-methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine</topic>
<topic>PAP</topic>
<topic>peroxidase-antiperoxidase</topic>
<topic>PB</topic>
<topic>phosphate buffer</topic>
<topic>TH</topic>
<topic>tyrosine hydroxylase</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Neuroscience</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>NSC</title>
</titleInfo>
<genre type="Journal">journal</genre>
<originInfo>
<dateIssued encoding="w3cdtf">199309</dateIssued>
</originInfo>
<identifier type="ISSN">0306-4522</identifier>
<identifier type="PII">S0306-4522(00)X0428-9</identifier>
<part>
<detail type="volume">
<number>56</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>2</number>
<caption>no.</caption>
</detail>
<extent unit="issue pages">
<start>263</start>
<end>522</end>
</extent>
<extent unit="pages">
<start>499</start>
<end>511</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7</identifier>
<identifier type="DOI">10.1016/0306-4522(93)90349-K</identifier>
<identifier type="PII">0306-4522(93)90349-K</identifier>
<identifier type="ArticleID">9390349K</identifier>
<accessCondition type="use and reproduction" contentType="">© 1993IBRO</accessCondition>
<recordInfo>
<recordContentSource>ELSEVIER</recordContentSource>
<recordOrigin>IBRO, ©1993</recordOrigin>
</recordInfo>
</mods>
</metadata>
<enrichments>
<istex:catWosTEI uri="https://api.istex.fr/document/A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7/enrichments/catWos">
<teiHeader>
<profileDesc>
<textClass>
<classCode scheme="WOS">NEUROSCIENCES</classCode>
</textClass>
</profileDesc>
</teiHeader>
</istex:catWosTEI>
</enrichments>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F44 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002F44 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:A9738CC06F8ADA2A4CFAD88E06E48E1CFA838CA7
   |texte=   Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024